Show simple item record

dc.contributor.authorSidhu, J.
dc.contributor.authorSaha, Vaskar
dc.contributor.authorKrishnan, Shekhar
dc.date.accessioned2021-09-30T11:56:15Z
dc.date.available2021-09-30T11:56:15Z
dc.date.issued2021en
dc.identifier.citationSidhu J, Saha V, Krishnan S. Reply to: Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India—Implications for clinical outcomes in acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2021 Sep 14.en
dc.identifier.pmid34519422en
dc.identifier.doi10.1002/pbc.29334en
dc.identifier.urihttp://hdl.handle.net/10541/624652
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1002/pbc.29334en
dc.titleReply to: Comment on: Unsatisfactory quality of E. coli asparaginase biogenerics in India-Implications for clinical outcomes in acute lymphoblastic leukaemiaen
dc.typeOtheren
dc.contributor.departmentDepartment of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, Indiaen
dc.identifier.journalPediatric Blood & Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record